VistaGen Therapeutics
VTGN
VTGN
55 hedge funds and large institutions have $8.84M invested in VistaGen Therapeutics in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
41.33% less ownership
Funds ownership: 76.15% → 34.82% (-41%)
89% less capital invested
Capital invested by funds: $81.8M → $8.84M (-$73M)
Holders
55
Holding in Top 10
–
Calls
$776K
Puts
$644K
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.26M | |
| 3 | +$900K | |
| 4 |
Jane Street
New York
|
+$811K |
| 5 |
Millennium Management
New York
|
+$637K |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$7.02M | |
| 3 | -$6.76M | |
| 4 |
CC
Commodore Capital
New York
|
-$5.59M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.95M |
